With more than 35 years of experience, the Ypsomed Group is the leading company in the manufacture of injection and infusion systems. Pharmaceutical and biotechnology companies from all over the world prefer the high-quality products of the Swiss innovation and technology leader. The Group has a global network and employs around 1,200 people worldwide. Due to the complete expansion of its production sites in Switzerland, Ypsomed decided to build another production facility in Europe. In a tough competition, Schwerin ultimately prevailed over sites in Switzerland and the Czech Republic.